Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
O-I Glass | OI | Apr 25, 2024 | 14.85 | -0.27 |
Oak Valley Bancorp | OVLY | Apr 25, 2024 | 24.07 | -2.90 |
Oak Woods Acquisition | OAKU | Apr 25, 2024 | 10.76 | 0.00 |
Oaktree Capital A Pref | OAK-A | Apr 25, 2024 | 21.69 | -0.72 |
Oaktree Capital Group B Pref | OAK-B | Apr 25, 2024 | 21.50 | -0.44 |
Oaktree Specialty | OCSL | Apr 25, 2024 | 19.67 | -0.10 |
Oatly ADR | OTLY | Apr 25, 2024 | 0.87 | -6.46 |
Oblong | OBLG | Apr 25, 2024 | 0.11 | -5.59 |
OCA Acquisition A | OCAX | Apr 25, 2024 | 10.94 | 0.00 |
Occidental Petroleum | OXY | Apr 25, 2024 | 67.88 | +0.82 |
Ocean Biomedical | OCEA | Apr 25, 2024 | 1.25 | -11.31 |
Ocean Power Technologies | OPTT | Apr 25, 2024 | 0.19 | +1.89 |
Oceaneering International | OII | Apr 25, 2024 | 24.55 | +6.51 |
OceanFirst Financial | OCFC | Apr 25, 2024 | 15.23 | -1.55 |
OceanFirst Pref | OCFCP | Apr 25, 2024 | 24.70 | +0.53 |
OceanPal | OP | Apr 25, 2024 | 2.35 | -3.69 |
Ocugen | OCGN | Apr 25, 2024 | 1.18 | 0.00 |
Ocular Therapeutix | OCUL | Apr 25, 2024 | 4.20 | -9.58 |
Oculis | OCS | Apr 25, 2024 | 11.95 | -0.25 |
Ocuphire Pharma | OCUP | Apr 25, 2024 | 1.53 | +0.33 |
Ocwen Financial | OCN | Apr 25, 2024 | 24.23 | -3.96 |
Oddity Tech | ODD | Apr 25, 2024 | 31.72 | -0.78 |
Odyssey Marine Exploration | OMEX | Apr 25, 2024 | 3.64 | +1.68 |
Offerpad Solutions A | OPAD | Apr 25, 2024 | 8.12 | +2.01 |
Office Properties | OPI | Apr 25, 2024 | 1.94 | -5.37 |
OFG Bancorp | OFG | Apr 25, 2024 | 36.46 | -1.38 |
OFS Capital | OFS | Apr 25, 2024 | 9.72 | +0.93 |
OFS Credit | OCCI | Apr 25, 2024 | 6.99 | -0.36 |
OFS Credit C Pref | OCCIO | Apr 25, 2024 | 23.75 | +0.13 |
OFS Credit E Pref | OCCIN | Apr 25, 2024 | 22.89 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.